The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Biased signalling: from simple switches to allosteric microprocessors
Open accessAbstract
G protein-coupled receptors (GPCRs) are the largest class of receptors in the human genome and some of the most common drug targets. It is now well established that GPCRs can signal through multiple transducers, including heterotrimeric G proteins, GPCR kinases and β-arrestins. While these signalling pathways can be activated or blocked by 'balanced' agonists or antagonists, they can also be selectively activated in a 'biased' response. Biased responses can be induced by biased ligands, biased receptors or system bias, any of which can result in preferential signalling through G proteins or β-arrestins. At many GPCRs, signalling events mediated by G proteins and β-arrestins have been shown to have distinct biochemical and physiological actions from one another, and an accurate evaluation of biased signalling from pharmacology through physiology is crucial for preclinical drug development. Recent structural studies have provided snapshots of GPCR–transducer complexes, which should aid in the structure-based design of novel biased therapies. Our understanding of GPCRs has evolved from that of two-state, on-and-off switches to that of multistate allosteric microprocessors, in which biased ligands transmit distinct structural information that is processed into distinct biological outputs. The development of biased ligands as therapeutics heralds an era of increased drug efficacy with reduced drug side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
A comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
De Lean, A., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,612
Self-citationStructural diversity of G protein-coupled receptors and significance for drug discovery
Lagerström, M. C., & Schiöth, H. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2518 · Cited by 1,492
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
Self-citationβ-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,384
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
Self-citationβ-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
Self-citationDifferential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
A MODIFICATION OF RECEPTOR THEORY
STEPHENSON, R. P. (1956) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1956.tb00006.x · Cited by 1,156
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Self-citationCXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,001
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
Beaulieu, J.-M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980
Self-citationSelective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical Practice
Riggs, B. L., & Hartmann, L. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022219 · Cited by 968
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Structure-based discovery of opioid analgesics with reduced side effects
Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., et al. (2016) · Nature · doi:10.1038/nature19112 · Cited by 944
Opportunities and challenges in phenotypic drug discovery: an industry perspective
Moffat, J. G., Vincent, F., Lee, J. A., Eder, J., & Prunotto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.111 · Cited by 939
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
Self-citationActivation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Structural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N., Sanborn, A. L., Kato, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 885
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Self-citationConformational biosensors reveal GPCR signalling from endosomes
Irannejad, R., Tomshine, J. C., Tomshine, J. R., Chevalier, M., Mahoney, J. P., Steyaert, J., Rasmussen, S. G. F., Sunahara, R. K., El-Samad, H., Huang, B., et al. (2013) · Nature · doi:10.1038/nature12000 · Cited by 819
Structure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O., Han, G. W., et al. (2015) · Nature · doi:10.1038/nature14656 · Cited by 807
The Dynamic Process of β2-Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Fung, J. J., Bokoch, M. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.008 · Cited by 796
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759
Self-citationPRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755
Allosteric Mechanisms of Signal Transduction
Changeux, J.-P., & Edelstein, S. J. (2005) · Science · doi:10.1126/science.1108595 · Cited by 747
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Hernandez, P. A., Gorlin, R. J., Lukens, J. N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M. E., & Diaz, G. A. (2003) · Nature Genetics · doi:10.1038/ng1149 · Cited by 722
β-arrestin-mediated receptor trafficking and signal transduction
Shenoy, S. K., & Lefkowitz, R. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.002 · Cited by 712
Self-citationBiased Signaling Pathways in β 2 -Adrenergic Receptor Characterized by 19 F-NMR
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., & Wüthrich, K. (2012) · Science · doi:10.1126/science.1215802 · Cited by 697
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
Self-citationGRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
Reiter, E., & Lefkowitz, R. J. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.008 · Cited by 666
Self-citationStructural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling
Manglik, A., Kim, T. H., Masureel, M., Altenbach, C., Yang, Z., Hilger, D., Lerch, M. T., Kobilka, T. S., Thian, F. S., Hubbell, W. L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.043 · Cited by 665
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
Crystal structure of metarhodopsin II
Choe, H.-W., Kim, Y. J., Park, J. H., Morizumi, T., Pai, E. F., Krauß, N., Hofmann, K. P., Scheerer, P., & Ernst, O. P. (2011) · Nature · doi:10.1038/nature09789 · Cited by 663
Benovic, J. L., Strasser, R. H., Caron, M. G., & Lefkowitz, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2797 · Cited by 662
Self-citationAgonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Nobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T.-Y., Bressler, E. A., Hara, M. R., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001707 · Cited by 626
Self-citationCXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., & Lagane, B. (2009) · Blood · doi:10.1182/blood-2008-12-196618 · Cited by 613
Bernard, Testa, M., Meyer, U., & Testa, B. (1964) · Academic Press eBooks · Cited by 609
Regulation of GPCRs by Endocytic Membrane Trafficking and Its Potential Implications
Hanyaloglu, A. C., & Zastrow, M. V. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094830 · Cited by 609
β-Arrestin-biased ligands at seven-transmembrane receptors
Violin, J. D., & Lefkowitz, R. J. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.006 · Cited by 606
Self-citationThe Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C., & Lefkowitz, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912852107 · Cited by 600
Self-citationA unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K., & Lefkowitz, R. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707936104 · Cited by 597
Self-citationKjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G., & Lefkowitz, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45962-5 · Cited by 589
Self-citationCryo-EM structure of the activated GLP-1 receptor in complex with a G protein
Zhang, Y., Sun, B., Feng, D., Hu, H., Chu, M., Qu, Q., Tarrasch, J. T., Li, S., Sun Kobilka, T., Kobilka, B. K., et al. (2017) · Nature · doi:10.1038/nature22394 · Cited by 576
Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000172 · Cited by 574
Sustained cyclic AMP production by parathyroid hormone receptor endocytosis
Ferrandon, S., Feinstein, T. N., Castro, M., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J.-P. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.206 · Cited by 572
Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32248 · Cited by 567
GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling
Thomsen, A. R. B., Plouffe, B., Cahill, T. J., Shukla, A. K., Tarrasch, J. T., Dosey, A. M., Kahsai, A. W., Strachan, R. T., Pani, B., Mahoney, J. P., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.004 · Cited by 563
Self-citationScreening out irrelevant cell-based models of disease
Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., Östling, P., Pietiäinen, V., Price, L. S., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.175 · Cited by 525
Rashighi, M., Agarwal, P., Richmond, J. M., Harris, T. H., Dresser, K., Su, M.-W., Zhou, Y., Deng, A., Hunter, C. A., Luster, A. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007811 · Cited by 518
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Self-citationVisualization of arrestin recruitment by a G-protein-coupled receptor
Shukla, A. K., Westfield, G. H., Xiao, K., Reis, R. I., Huang, L.-Y., Tripathi-Shukla, P., Qian, J., Li, S., Blanc, A., Oleskie, A. N., et al. (2014) · Nature · doi:10.1038/nature13430 · Cited by 510
Self-citationZhang, J., Ferguson, S. S. G., Barak, L. S., Bodduluri, S. R., Laporte, S. A., Law, P.-Y., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7157 · Cited by 505
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A., & Novick, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200111m · Cited by 484
The structural basis of agonist-induced activation in constitutively active rhodopsin
Standfuss, J., Edwards, P. C., D’Antona, A., Fransen, M., Xie, G., Oprian, D. D., & Schertler, G. F. X. (2011) · Nature · doi:10.1038/nature09795 · Cited by 476
Phase-plate cryo-EM structure of a class B GPCR–G-protein complex
Liang, Y.-L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J., Thal, D. M., Furness, S. G. B., Christopoulos, G., Coudrat, T., et al. (2017) · Nature · doi:10.1038/nature22327 · Cited by 462
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., Lansu, K., Schools, Z. L., Che, T., Nichols, D. E., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.033 · Cited by 457
Diversity and modularity of G protein-coupled receptor structures
Katritch, V., Cherezov, V., & Stevens, R. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.09.003 · Cited by 456
Structure of the adenosine A2A receptor bound to an engineered G protein
Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. W., & Tate, C. G. (2016) · Nature · doi:10.1038/nature18966 · Cited by 435
A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation
Barak, L. S., Ferguson, S. S. G., Zhang, J., & Caron, M. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27497 · Cited by 428
Structure of class B GPCR corticotropin-releasing factor receptor 1
Hollenstein, K., Kean, J., Bortolato, A., Cheng, R. K. Y., Doré, A. S., Jazayeri, A., Cooke, R. M., Weir, M., & Marshall, F. H. (2013) · Nature · doi:10.1038/nature12357 · Cited by 416
Functional Dissociation of μ Opioid Receptor Signaling and Endocytosis
Whistler, J. L., Chuang, H.-H., Chu, P., Jan, L. Y., & von Zastrow, M. (1999) · Neuron · doi:10.1016/s0896-6273(01)80032-5 · Cited by 413
Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
Paige, L. A., Christensen, D. J., Grøn, H., Norris, J. D., Gottlin, E. B., Padilla, K. M., Chang, C.-Y., Ballas, L. M., Hamilton, P. T., McDonnell, D. P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3999 · Cited by 412
Laporte, S. A., Oakley, R. H., Holt, J. A., Barak, L. S., & Caron, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002581200 · Cited by 401
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Rajagopal, S., Ahn, S., Rominger, D. H., Gowen-MacDonald, W., Lam, C. M., DeWire, S. M., Violin, J. D., & Lefkowitz, R. J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072801 · Cited by 388
Self-citationStructure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography
Zhang, H., Unal, H., Gati, C., Han, G. W., Liu, W., Zatsepin, N. A., James, D., Wang, D., Nelson, G., Weierstall, U., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.011 · Cited by 382
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J.-P., Chung, C.-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E., & Nar, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.123 · Cited by 382
Cahill, T. J., Thomsen, A. R. B., Tarrasch, J. T., Plouffe, B., Nguyen, A. H., Yang, F., Huang, L.-Y., Kahsai, A. W., Bassoni, D. L., Gavino, B. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701529114 · Cited by 379
Self-citationPeptide Antagonists of the Human Estrogen Receptor
Norris, J. D., Paige, L. A., Christensen, D. J., Chang, C.-Y., Huacani, M. R., Fan, D., Hamilton, P. T., Fowlkes, D. M., & McDonnell, D. P. (1999) · Science · doi:10.1126/science.285.5428.744 · Cited by 373
Biased ligands at G-protein-coupled receptors: promise and progress
Violin, J. D., Crombie, A. L., Soergel, D. G., & Lark, M. W. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.007 · Cited by 363
The evasive nature of drug efficacy: implications for drug discovery
Galandrin, S., Oligny-Longpré, G., & Bouvier, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.005 · Cited by 363
TGFα shedding assay: an accurate and versatile method for detecting GPCR activation
Inoue, A., Ishiguro, J., Kitamura, H., Arima, N., Okutani, M., Shuto, A., Higashiyama, S., Ohwada, T., Arai, H., Makide, K., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2172 · Cited by 360
Allen, J. A., Yost, J. M., Setola, V., Chen, X., Sassano, M. F., Chen, M., Peterson, S., Yadav, P. N., Huang, X.-P., Feng, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104807108 · Cited by 350
Kim, J., Ahn, S., Ren, X.-R., Whalen, E. J., Reiter, E., Wei, H., & Lefkowitz, R. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409532102 · Cited by 349
Self-citationNamkung, Y., Le Gouill, C., Lukashova, V., Kobayashi, H., Hogue, M., Khoury, E., Song, M., Bouvier, M., & Laporte, S. A. (2016) · Nature Communications · doi:10.1038/ncomms12178 · Cited by 347
CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
Décaillot, F. M., Kazmi, M. A., Lin, Y., Ray-Saha, S., Sakmar, T. P., & Sachdev, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277038 · Cited by 333
Kohout, T. A., Nicholas, S. L., Perry, S. J., Reinhart, G., Junger, S., & Struthers, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402125200 · Cited by 333
Staus, D. P., Strachan, R. T., Manglik, A., Pani, B., Kahsai, A. W., Kim, T. H., Wingler, L. M., Ahn, S., Chatterjee, A., Masoudi, A., et al. (2016) · Nature · doi:10.1038/nature18636 · Cited by 330
Self-citationBalabanian, K. (2005) · Blood · doi:10.1182/blood-2004-06-2289 · Cited by 322
Identification of β-Arrestin2 as a G Protein-Coupled Receptor-Stimulated Regulator of NF-κB Pathways
Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., & Pei, G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00216-3 · Cited by 312
Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Heydenreich, F. M., Flock, T., Miljus, T., Balaji, S., Bouvier, M., Veprintsev, D. B., Tate, C. G., et al. (2016) · Nature · doi:10.1038/nature19107 · Cited by 308
Land, B. B., Bruchas, M. R., Schattauer, S., Giardino, W. J., Aita, M., Messinger, D., Hnasko, T. S., Palmiter, R. D., & Chavkin, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910705106 · Cited by 301
The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors
Smith, J. S., & Rajagopal, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.713313 · Cited by 294
Self-citationMüller, M., Carter, S., Hofer, M. J., & Campbell, I. L. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01089.x · Cited by 293
CXCR4 and CXCR7 Have Distinct Functions in Regulating Interneuron Migration
Wang, Y., Li, G., Stanco, A., Long, J. E., Crawford, D., Potter, G. B., Pleasure, S. J., Behrens, T., & Rubenstein, J. L. R. (2011) · Neuron · doi:10.1016/j.neuron.2010.12.005 · Cited by 290
Recent developments in biased agonism
Wisler, J. W., Xiao, K., Thomsen, A. R., & Lefkowitz, R. J. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.10.008 · Cited by 287
Self-citationStructure of CC chemokine receptor 2 with orthosteric and allosteric antagonists
Zheng, Y., Qin, L., Zacarías, N. V. O., de Vries, H., Han, G. W., Gustavsson, M., Dabros, M., Zhao, C., Cherney, R. J., Carter, P., et al. (2016) · Nature · doi:10.1038/nature20605 · Cited by 284
Busillo, J. M., Armando, S., Sengupta, R., Meucci, O., Bouvier, M., & Benovic, J. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091173 · Cited by 281
Zidar, D. A., Violin, J. D., Whalen, E. J., & Lefkowitz, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904361106 · Cited by 278
Self-citationβ-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804745105 · Cited by 276
Structural basis for chemokine recognition and activation of a viral G protein–coupled receptor
Burg, J. S., Ingram, J. R., Venkatakrishnan, A. J., Jude, K. M., Dukkipati, A., Feinberg, E. N., Angelini, A., Waghray, D., Dror, R. O., Ploegh, H. L., et al. (2015) · Science · doi:10.1126/science.aaa5026 · Cited by 273
Bruchas, M. R., Schindler, A. G., Shankar, H., Messinger, D. I., Miyatake, M., Land, B. B., Lemos, J. C., Hagan, C. E., Neumaier, J. F., Quintana, A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.011 · Cited by 267
Soergel, D. G., Subach, R. A., Burnham, N., Lark, M. W., James, I. E., Sadler, B. M., Skobieranda, F., Violin, J. D., & Webster, L. R. (2014) · Pain · doi:10.1016/j.pain.2014.06.011 · Cited by 262
Intracellular allosteric antagonism of the CCR9 receptor
Oswald, C., Rappas, M., Kean, J., Doré, A. S., Errey, J. C., Bennett, K., Deflorian, F., Christopher, J. A., Jazayeri, A., Mason, J. S., et al. (2016) · Nature · doi:10.1038/nature20606 · Cited by 259
Role of kappa-opioid receptors in stress and anxiety-related behavior
Van’t Veer, A., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 257
Multiple ligand-specific conformations of the β2-adrenergic receptor
Kahsai, A. W., Xiao, K., Rajagopal, S., Ahn, S., Shukla, A. K., Sun, J., Oas, T. G., & Lefkowitz, R. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.634 · Cited by 250
Self-citationBarak, L. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011303698 · Cited by 249
Brust, T. F., Morgenweck, J., Kim, S. A., Rose, J. H., Locke, J. L., Schmid, C. L., Zhou, L., Stahl, E. L., Cameron, M. D., Scarry, S. M., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aai8441 · Cited by 240
Structural flexibility of the Gαs α-helical domain in the β 2 -adrenoceptor Gs complex
Westfield, G. H., Rasmussen, S. G. F., Su, M., Dutta, S., DeVree, B. T., Chung, K. Y., Calinski, D., Velez-Ruiz, G., Oleskie, A. N., Pardon, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113645108 · Cited by 235
Biased signalling and allosteric machines: new vistas and challenges for drug discovery
Kenakin, T. P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01749.x · Cited by 233
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
Shukla, A. K., Violin, J. D., Whalen, E. J., Gesty-Palmer, D., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804246105 · Cited by 231
Self-citationGroer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., & Bohn, L. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028258 · Cited by 224
β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation
Eichel, K., Jullié, D., & von Zastrow, M. (2016) · Nature Cell Biology · doi:10.1038/ncb3307 · Cited by 221
Advances in G Protein-Coupled Receptor Allostery: From Function to Structure
Christopoulos, A. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094342 · Cited by 220
Structural basis for selectivity and diversity in angiotensin II receptors
Zhang, H., Han, G. W., Batyuk, A., Ishchenko, A., White, K. L., Patel, N., Sadybekov, A., Zamlynny, B., Rudd, M. T., Hollenstein, K., et al. (2017) · Nature · doi:10.1038/nature22035 · Cited by 220
The conformational signature of β-arrestin2 predicts its trafficking and signalling functions
Lee, M.-H., Appleton, K. M., Strungs, E. G., Kwon, J. Y., Morinelli, T. A., Peterson, Y. K., Laporte, S. A., & Luttrell, L. M. (2016) · Nature · doi:10.1038/nature17154 · Cited by 218
Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory.
Ej, A. (1954) · PubMed · Cited by 218
Extra-helical binding site of a glucagon receptor antagonist
Jazayeri, A., Doré, A. S., Lamb, D., Krishnamurthy, H., Southall, S. M., Baig, A. H., Bortolato, A., Koglin, M., Robertson, N. J., Errey, J. C., et al. (2016) · Nature · doi:10.1038/nature17414 · Cited by 216
Viscusi, E. R., Webster, L., Kuss, M., Daniels, S., Bolognese, J. A., Zuckerman, S., Soergel, D. G., Subach, R. A., Cook, E., & Skobieranda, F. (2016) · Pain · doi:10.1097/j.pain.0000000000000363 · Cited by 205
β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle
Nuber, S., Zabel, U., Lorenz, K., Nuber, A., Milligan, G., Tobin, A. B., Lohse, M. J., & Hoffmann, C. (2016) · Nature · doi:10.1038/nature17198 · Cited by 205
Yang, F., Yu, X., Liu, C., Qu, C.-X., Gong, Z., Liu, H.-D., Li, F.-H., Wang, H.-M., He, D.-F., Yi, F., et al. (2015) · Nature Communications · doi:10.1038/ncomms9202 · Cited by 204
White, K. L., Robinson, J. E., Zhu, H., DiBerto, J. F., Polepally, P. R., Zjawiony, J. K., Nichols, D. E., Malanga, C. J., & Roth, B. L. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216820 · Cited by 203
Differential G-protein-coupled Receptor Phosphorylation Provides Evidence for a Signaling Bar Code
Butcher, A. J., Prihandoko, R., Kong, K. C., McWilliams, P., Edwards, J. M., Bottrill, A., Mistry, S., & Tobin, A. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154526 · Cited by 202
Drury, L. J., Ziarek, J. J., Gravel, S., Veldkamp, C. T., Takekoshi, T., Hwang, S. T., Heveker, N., Volkman, B. F., & Dwinell, M. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101133108 · Cited by 201
Novel Allosteric Modulators of G Protein-coupled Receptors
Gentry, P. R., Sexton, P. M., & Christopoulos, A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.662759 · Cited by 199
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
Luttrell, L. M., Maudsley, S., & Bohn, L. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099630 · Cited by 190
Applications of chemogenomic library screening in drug discovery
Jones, L. H., & Bunnage, M. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.244 · Cited by 188
Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor
Zhang, H., Unal, H., Desnoyer, R., Han, G. W., Patel, N., Katritch, V., Karnik, S. S., Cherezov, V., & Stevens, R. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.689000 · Cited by 187
Development of κ Opioid Receptor Antagonists
Carroll, F. I., & Carlezon, W. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301783x · Cited by 185
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons
Ehrich, J. M., Messinger, D. I., Knakal, C. R., Kuhar, J. R., Schattauer, S. S., Bruchas, M. R., Zweifel, L. S., Kieffer, B. L., Phillips, P. E. M., & Chavkin, C. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2444-15.2015 · Cited by 184
Zohar, Y., Wildbaum, G., Novak, R., Salzman, A. L., Thelen, M., Alon, R., Barsheshet, Y., Karp, C. L., & Karin, N. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71951 · Cited by 184
Biased and G Protein-Independent Signaling of Chemokine Receptors
Steen, A., Larsen, O., Thiele, S., & Rosenkilde, M. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00277 · Cited by 181
Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor
Isogai, S., Deupi, X., Opitz, C., Heydenreich, F. M., Tsai, C.-J., Brueckner, F., Schertler, G. F. X., Veprintsev, D. B., & Grzesiek, S. (2016) · Nature · doi:10.1038/nature16577 · Cited by 177
Quoyer, J., Janz, J. M., Luo, J., Ren, Y., Armando, S., Lukashova, V., Benovic, J. L., Carlson, K. E., Hunt, S. W., & Bouvier, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312515110 · Cited by 173
Charest, P. G., Terrillon, S., & Bouvier, M. (2005) · EMBO reports · doi:10.1038/sj.embor.7400373 · Cited by 172
Crystal structure of pre-activated arrestin p44
Kim, Y. J., Hofmann, K. P., Ernst, O. P., Scheerer, P., Choe, H.-W., & Sommer, M. E. (2013) · Nature · doi:10.1038/nature12133 · Cited by 170
Functional competence of a partially engaged GPCR–β-arrestin complex
Kumari, P., Srivastava, A., Banerjee, R., Ghosh, E., Gupta, P., Ranjan, R., Chen, X., Gupta, B., Gupta, C., Jaiman, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms13416 · Cited by 168
Crystal structure of a common GPCR-binding interface for G protein and arrestin
Szczepek, M., Beyrière, F., Hofmann, K. P., Elgeti, M., Kazmin, R., Rose, A., Bartl, F. J., von Stetten, D., Heck, M., Sommer, M. E., et al. (2014) · Nature Communications · doi:10.1038/ncomms5801 · Cited by 164
The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism
Wootten, D., Reynolds, C. A., Smith, K. J., Mobarec, J. C., Koole, C., Savage, E. E., Pabreja, K., Simms, J., Sridhar, R., Furness, S. G. B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.023 · Cited by 164
Sexton, P. M., Findlay, D. M., & Martin, T. J. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730611220401164504 · Cited by 163
Gregory, K. J., Hall, N. E., Tobin, A. B., Sexton, P. M., & Christopoulos, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094011 · Cited by 159
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
Ahn, S., Kim, J., Hara, M. R., Ren, X.-R., & Lefkowitz, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808463200 · Cited by 159
Self-citationDevelopment of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors
Zhou, L., Lovell, K. M., Frankowski, K. J., Slauson, S. R., Phillips, A. M., Streicher, J. M., Stahl, E. L., Schmid, C. L., Hodder, P., Madoux, F., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.504381 · Cited by 158
Urs, N. M., Gee, S. M., Pack, T. F., McCorvy, J. D., Evron, T., Snyder, J. C., Yang, X., Rodriguiz, R. M., Borrelli, E., Wetsel, W. C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614347113 · Cited by 158
Poulin, B., Butcher, A. J., McWilliams, P., Bourgognon, J.-M., Pawlak, R., Kong, K. C., Bottrill, A. R., Mistry, S. C., Wess, J., Rosethorne, E. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914801107 · Cited by 156
Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling
Melief, E. J., Miyatake, M., Bruchas, M. R., & Chavkin, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000751107 · Cited by 154
Wardell, S. E., Marks, J. R., & McDonnell, D. P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.03.031 · Cited by 152
Welihinda, A. A., Kaur, M., Greene, K., Zhai, Y., & Amento, E. P. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.010 · Cited by 152
Dynorphin, dysphoria and dependence: the stress of addiction
Chavkin, C., & Koob, G. F. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.258 · Cited by 149
Multiple mechanisms of serotonergic signal transduction
Roth, B. L., & Chuang, D. M. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90621-7 · Cited by 148
Strachan, R. T., Sun, J., Rominger, D. H., Violin, J. D., Ahn, S., Thomsen, A. R. B., Zhu, X., Kleist, A. B., Costa, T., & Lefkowitz, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548131 · Cited by 146
Self-citationIdentification of Novel Functionally Selective κ-Opioid Receptor Scaffolds
White, K. L., Scopton, A. P., Rives, M., Bikbulatov, R. V., Polepally, P. R., Brown, P. J., Kenakin, T., Javitch, J. A., Zjawiony, J. K., & Roth, B. L. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.089649 · Cited by 146
The Dynamic Process of b 2 -Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Bokoch, M. P., Thian, F. S., et al. (2013) · Cited by 146
Ahn, K. H., Mahmoud, M. M., Shim, J., & Kendall, D. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438804 · Cited by 145
Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors
Rajagopal, S., Bassoni, D. L., Campbell, J. J., Gerard, N. P., Gerard, C. J., & Wehrman, T. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.479113 · Cited by 144
Self-citationChen, X., Sassano, M. F., Zheng, L., Setola, V., Chen, M., Bai, X., Frye, S. V., Wetsel, W. C., Roth, B. L., & Jin, J. J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300603y · Cited by 141
New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy
Urs, N. M., Peterson, S. M., & Caron, M. G. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.011 · Cited by 137
Minireview: More Than Just a Hammer: Ligand “Bias” and Pharmaceutical Discovery
Luttrell, L. M. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1314 · Cited by 136
β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression
Girnita, L., Shenoy, S. K., Sehat, B., Vasilcanu, R., Vasilcanu, D., Girnita, A., Lefkowitz, R. J., & Larsson, O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611526200 · Cited by 134
Self-citationAurelio, L., Valant, C., Flynn, B. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9002582 · Cited by 134
Ligand-Dependent Modulation of G Protein Conformation Alters Drug Efficacy
Furness, S. G. B., Liang, Y.-L., Nowell, C. J., Halls, M. L., Wookey, P. J., Dal Maso, E., Inoue, A., Christopoulos, A., Wootten, D., & Sexton, P. M. (2016) · Cell · doi:10.1016/j.cell.2016.09.021 · Cited by 134
Nakajima, K., & Wess, J. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080358 · Cited by 132
Kovalenko, M. V., Rönnstrand, L., Heldin, C., Loubtchenkov, M., Gazit, A., Levitzki, A., & Böhmer, F. (1997) · Biochemistry · doi:10.1021/bi962553l · Cited by 129
Gurwitz, D., Haring, R., Heldman, E., Fraser, C. M., Manor, D., & Fisher, A. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90220-8 · Cited by 129
Schattauer, S. S., Kuhar, J. R., Song, A. J., & Chavkin, C. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.01.016 · Cited by 128
Griffin, M. T., Figueroa, K. W., Liller, S., & Ehlert, F. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120857 · Cited by 123
Biased Signaling at Chemokine Receptors
Corbisier, J., Galès, C., Huszagh, A., Parmentier, M., & Springael, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.596098 · Cited by 121
Valant, C., May, L. T., Aurelio, L., Chuo, C. H., White, P. J., Baltos, J., Sexton, P. M., Scammells, P. J., & Christopoulos, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320962111 · Cited by 119
Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling
Liu, C.-H., Gong, Z., Liang, Z.-L., Liu, Z.-X., Yang, F., Sun, Y., Ma, M.-L., Wang, Y.-J., Ji, C.-R., Wang, Y.-H., et al. (2017) · Nature Communications · doi:10.1038/ncomms14335 · Cited by 116
Mary, S., Damian, M., Louet, M., Floquet, N., Fehrentz, J., Marie, J., Martínez, J., & Banères, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119881109 · Cited by 114
Rives, M., Rossillo, M., Liu‐Chen, L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.387332 · Cited by 111
Berchiche, Y. A., & Sakmar, T. P. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105502 · Cited by 111
Melief, E. J., Miyatake, M., Carroll, F. I., Béguin, C., Carlezon, W. A., Cohen, B. M., Grimwood, S., Mitch, C. H., Rorick‐Kehn, L. M., & Chavkin, C. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074195 · Cited by 109
Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits
Spangler, S. M., & Bruchas, M. R. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.11.001 · Cited by 109
β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1
Mancini, A. D., Bertrand, G., Vivot, K., Carpentier, É., Tremblay, C. C., Ghislain, J. J., Bouvier, M., & Poitout, V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.644450 · Cited by 101
Jarpe, M. B., Knall, C., Mitchell, F. M., Buhl, A. M., Duzic, E., & Johnson, G. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.3097 · Cited by 101
Optodynamic simulation of β-adrenergic receptor signalling
Siuda, E. R., McCall, J. G., Al‐Hasani, R., Shin, G., Park, S. I., Schmidt, M. J., Anderson, S. L., Planer, W., Rogers, J. A., & Bruchas, M. R. (2015) · Nature Communications · doi:10.1038/ncomms9480 · Cited by 101
Multiplexing of Multicolor Bioluminescence Resonance Energy Transfer
Breton, B., Sauvageau, É., Zhou, J., Bonin, H., Gouill, C. L., & Bouvier, M. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.10.025 · Cited by 95
Devost, D., Sleno, R., Pétrin, D., Zhang, A., Shinjo, Y., Okde, R., Aoki, J., Inoue, A., & Hébert, T. E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.763854 · Cited by 95
A Structure–Activity Analysis of Biased Agonism at the Dopamine D2 Receptor
Shonberg, J., Herenbrink, C. K., López, L., Christopoulos, A., Scammells, P. J., Capuano, B., & Lane, J. R. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401318w · Cited by 91
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
Munro, T. A., Berry, L., Veer, A. V., Béguin, C., Carroll, F. I., Zhao, Z., Carlezon, W. A., & Cohen, B. M. (2012) · BMC Pharmacology · doi:10.1186/1471-2210-12-5 · Cited by 91
Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias
Andreassen, K. V., Hjuler, S. T., Furness, S. G., Sexton, P. M., Christopoulos, A., Nosjean, O., Karsdal, M. A., & Henriksen, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092042 · Cited by 89
Conformationally selective RNA aptamers allosterically modulate the β2-adrenoceptor
Kahsai, A. W., Wisler, J. W., Lee, J., Ahn, S., Cahill, T. J., Dennison, S. M., Staus, D. P., Thomsen, A. R. B., Anasti, K. M., Pani, B., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2126 · Cited by 88
Self-citationMallipeddi, S., Janero, D. R., Zvonok, N., & Makriyannis, A. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.014 · Cited by 88
Free, R. B., Chun, L. S., Moritz, A. E., Miller, B. N., Doyle, T. B., Conroy, J., Padron, A., Meade, J. A., Xiao, J., Hu, X., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.090563 · Cited by 87
Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor
Felker, G. M., Butler, J., Collins, S. P., Cotter, G., Davison, B. A., Ezekowitz, J. A., Filippatos, G. S., Levy, P. D., Metra, M., Ponikowski, P. P., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.09.008 · Cited by 85
Perez‐Aguilar, J. M., Shan, J., Levine, M. V., Khelashvili, G., & Weinstein, H. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508394x · Cited by 83
Park, S. M., Chen, M., Schmerberg, C. M., Dulman, R. S., Rodriguiz, R. M., Caron, M. G., Jin, J. J., & Wetsel, W. C. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.196 · Cited by 74
Measurements of ligand bias and functional affinity
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954-c2 · Cited by 74
Onaran, H. O., Ambrosio, C., Uğur, Ö., Koncz, E. M., Grò, M. C., Vezzi, V., Rajagopal, S., & Costa, T. (2017) · Scientific Reports · doi:10.1038/srep44247 · Cited by 71
Self-citationβ-Arrestin1–Biased β 1 -Adrenergic Receptor Signaling Regulates MicroRNA Processing
Kim, I., Wang, Y., Park, K., Tang, Y., Teoh, J., Vinson, J., Traynham, C. J., Pironti, G., Mao, L., Su, H., et al. (2013) · Circulation Research · doi:10.1161/circresaha.114.302766 · Cited by 70
Noribogaine is a G-protein biased κ-opioid receptor agonist
Maillet, É. L., Milon, N., Heghinian, M. D., Fishback, J. A., Schürer, S. C., Garamszegi, N., & Mash, D. C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.032 · Cited by 67
Smith, J. S., Alagesan, P., Desai, N. K., Pack, T. F., Wu, J., Inoue, A., Freedman, N. J., & Rajagopal, S. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108522 · Cited by 67
Self-citationAdenosine and cardioprotection during reperfusion – an overview
Donato, M., & Gelpi, R. J. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1025454504577 · Cited by 66
Wootten, D. L., Reynolds, C. A., Koole, C., Smith, K. J., Mobarec, J. C., Simms, J., Quon, T., Coudrat, T., Furness, S. G. B., Miller, L. J., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.101246 · Cited by 66
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Common activation mechanism of class A GPCRs
Zhou, Q., Yang, D., Wu, M., Guo, Y., Guo, W., Zhong, L., Cai, X., Dai, A., Jang, W., Shakhnovich, E. I., et al. (2019) · eLife · doi:10.7554/elife.50279 · Cited by 632
G protein-coupled receptors: structure- and function-based drug discovery
Yang, D., Zhou, Q., Labroska, V., Qin, S., Darbalaei, S., Wu, Y., Yuliantie, E., Xie, L., Tao, H., Cheng, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00435-w · Cited by 632
Sex differences in anxiety and depression: circuits and mechanisms
Bangasser, D. A., & Cuarenta, A. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00513-0 · Cited by 479
Metadata
- Authors
- Smith, J. S., Lefkowitz, R. J., & Rajagopal, S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2018-01-05
- Volume
- 17
- Issue
- 4
- Pages
- 243-260
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2782408527
- Cited by
- 738
- References
- 220
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.